Edge Wealth Management LLC Biocryst Pharmaceuticals Inc Transaction History

Edge Wealth Management LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Jan 14, 2022	BUY	$11.18 - $15.46 $111,800 - $154,600	10,000 Added 40.0%	35,000 $485,000
Q3 2021 Oct 13, 2021	SELL	$14.21 - $17.65 $355,250 - $441,249	-25,000 Reduced 50.0%	25,000 $359,000
Q1 2021 Apr 09, 2021	SELL	$7.37 - $13.61 $442,273 - $816,736	-60,010 Reduced 54.55%	50,000 $509,000
Q4 2020 Jan 19, 2021	SELL	$3.37 - $8.61 $376,156 - $961,039	-111,619 Reduced 50.36%	110,010 $822,000
Q3 2020 Oct 21, 2020	BUY	$3.43 - $5.53 $122,451 - $197,421	35,700 Added 19.2%	221,629 $761,000
Q2 2020 Aug 03, 2020	BUY	$1.9 - $5.61 $353,265 - $1.04 Million	185,929 New	185,929 $886,000

279

172M

625K

739K

Ticker BCRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,944,992
Market Cap $1.41B
Description
BioCryst Pharmaceuticals, Inc., a biotechnology company, discovers novel, oral, and small-molecule medicines. The company markets peramivir injection, an intravenous neuraminidase inhibitor for the treatment of acute uncomplicated influenza under the RAPIVAB, RAPIACTA, and PERAMIFLU names; and ORLADEYO, an oral serine protease inhibitor to treat...

Get notified when there are updates to the investment portfolio of Edge Wealth Management LLC, based on Form 13F filings with the SEC.

Stay updated on Edge Wealth Management LLC with notifications on news.